Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

Results support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

Expression of the clusterin gene in hematopoietic stem cells marks an age-related shift toward myeloid/platelet over lymphoid cell production In recent years, there has been a growing trend of an ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the ...

Red blood cells carry oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to keep the oxygen flowing. For many years, ...